# Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Effectiveness

> **NCT03077919** · NA · COMPLETED · sponsor: **RTI International** · enrollment: 113 (actual)

## Conditions studied

- PostTraumatic Stress Disorder

## Interventions

- **DRUG:** Ropivacaine
- **DRUG:** Sham treatment

## Key facts

- **NCT ID:** NCT03077919
- **Lead sponsor:** RTI International
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-25
- **Primary completion:** 2018-06-09
- **Final completion:** 2018-06-09
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2020-05-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03077919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03077919, "Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Effectiveness". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03077919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*